New York State Common Retirement Fund
SGMT icon

New York State Common Retirement Fund’s Sagimet Biosciences SGMT Stock Holding History

New York State Common Retirement Fund’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109K Buy
+14,100
New +$95.9K ﹤0.01% 2637
2024
Q3 		– Sell
-195
Closed -$667 – 3318
2024
Q2 		$667 Sell
195
-6,148
-97% -$28.2K ﹤0.01% 3312
2024
Q1 		$34.4K Sell
6,343
-14
-0.2% -$101 ﹤0.01% 3072
2023
Q4 		$34.5K Hold
6,357
– – ﹤0.01% 3078
2023
Q3 		$55.9K Buy
+6,357
New +$84.6K ﹤0.01% 2988

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

New York State Common Retirement Fund's SGMT Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Sagimet Biosciences (SGMT) in Q2 2026: 14,100 shares worth $109K. The stake represents ﹤0.01% of the portfolio and ranks #2637 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in SGMT as recently as Q2 2024.

New York State Common Retirement Fund first reported a position in SGMT in Q3 2023 and has held it in 5 quarters since. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • New York State Common Retirement Fund held 14,100 shares of Sagimet Biosciences worth $109K as of Q2 2026.
  • Sagimet Biosciences was a new New York State Common Retirement Fund position in Q2 2026.
  • Sagimet Biosciences made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2637 holding.
  • New York State Common Retirement Fund first reported a position in Sagimet Biosciences in Q3 2023 and has held it in 5 quarters since.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.